Hamm Robert A 4
4 · BIOGEN IDEC INC. · Filed Feb 25, 2010
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Hamm Robert A
EVP, Pharma. Oper. & Tech.
Transactions
- Award
Common Stock
2010-02-24+9,306→ 32,252.41 total - Tax Payment
Common Stock
2010-02-24$55.29/sh−985$54,461→ 31,267.41 total - Tax Payment
Common Stock
2010-02-24$55.29/sh−996$55,069→ 30,271.41 total - Award
Restricted Stock Unit
2010-02-23+48,916→ 48,916 totalExercise: $0.00Exp: 2014-02-23→ Common Stock (48,916 underlying)
Footnotes (2)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
- [F2]There is no conversion or exercise price for this stock unit.